Home › Acute Lymphoblastic Leukemia › NCT03481881
Pharmacokinetics of Drugs Administered to Children
RecruitingObservational study
Pharmacokinetics of Drugs Administered to Children Per Standard of Care
Who can join
Ages 0 to 20 · All sexes
Full eligibility criteria
Inclusion Criteria: * Children (\< 21 years of age) who are receiving understudied drugs of interest per standard of care as prescribed by their treating caregiver Exclusion Criteria: * Failure to obtain consent/assent (as indicated)
About the study
This is a prospective study of children \<21 years of age with the goal of characterizing the PK of drugs administered per standard of care as prescribed by the treating caregiver.
What is being tested
- Standard of care drug (drug)
Sponsor: Duke University · Participants: 200 · Started: Aug 14, 2013
Contact the study team
- Rachel G Greenberg, MD · Phone: 9196684725
Official record on ClinicalTrials.gov — NCT03481881
Locations in the U.S.
| North Carolina | Duke University, Durham |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.